The Plant Company, a commercial houseplant producer in Stuarts Draft, Virginia, says it is taking over a collection of approximately 150 Dracaena mutations developed by Dutch growers Ruud and Agnes Scheffers of Dragontree. The agreement, reported on 9 October 2026 as the breeders prepare to retire, concerns breeding and selection material rather than 150 varieties ready for sale.
The US company confirmed the plan in its own announcement. The growers began cultivating Dracaena in the Netherlands in 1985, building a collection of plants with differences in foliage colour, variegation, leaf shape and growth characteristics. The Plant Company says it intends to preserve and evaluate that material for possible future commercial introductions.
A transfer of breeding potential, not finished products
According to the report carrying the company’s detailed statement, the final portion of the collection is being transferred to The Plant Company’s facilities in Virginia. Once the plants are established, its team plans to test the selections through propagation and production trials. Those trials will determine whether individual plants are stable, practical to grow at scale and suitable for release.
The company’s chief operating officer, Frank Paul, described the incoming material as decades of accumulated plant knowledge. The group expects evaluation and development to take several years, with introductions possible only as selections pass successive production tests.
Why the transaction matters for nurseries
The asset is a genetics pipeline: a pool of distinct plant material that could support future ornamental varieties. For professional growers and young-plant suppliers, value depends less on the count of mutations than on which can be propagated consistently, perform reliably in greenhouse production and ultimately meet retailer demand.
The Plant Company produces houseplants for the Proven Winners leafjoy programme. Its company information describes a professional greenhouse operation in Stuarts Draft with propagation, climate-control and growing infrastructure. No published evidence establishes that the incoming collection will immediately increase commercial output or result in a fixed number of leafjoy launches.
The new transfer should not be confused with the earlier European cutting-sales licence discussed separately by the Dutch breeder. The rights covered by the current US collection agreement have not been described in sufficient detail to treat the two arrangements as the same transaction.
What remains unclear
The companies have not disclosed the purchase price, the precise scope of intellectual-property or licensing rights, or a date for the first saleable new cultivar. Individual selections will need successful trials before they can be treated as commercial products.
Key takeaways
- The Plant Company plans to take over approximately 150 Dracaena breeding selections from Dutch growers retiring after decades in the crop.
- Material is moving to Virginia for propagation and evaluation; the company has not launched 150 new varieties.
- Commercial value and timing depend on multi-year stability and production trials, while transaction terms remain undisclosed.
